Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 04 Mar 2023
United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...
Read Full NewsWechsler discusses why less frequent dosing matters to patients with severe asthma, plus VALIANT's safety profile and what's next for the field.
Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD
Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations
Adults with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive now have a second self-administration option for the complement inhibitor zilucoplan.
Three-year extension data from the phase 3 IB1001-301 trial show levacetylleucine slowed disease progression in both adults and children with Niemann-Pick disease type C.
Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era
1.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
2.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
3.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
4.
Lesser-known lobular breast cancer on the rise in U.S. women
5.
Prostate cancer death risk is higher in late teens and early 20s weight gain.
1.
Public Health Through Cancer Survivorship Infrastructure at the Community Level
2.
Integrated Updates in Oncology for Specialists
3.
PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
Degraders for Endocrine-Resistant Tumors: Mechanisms, Clinical Applications, and Emerging Therapeutic Strategies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
2.
Signs and Symptoms of Leukemia
3.
Navigating the Complexities of Ph Negative ALL - Part XI
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge